SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Picks of the quarter -- Ignore unavailable to you. Want to Upgrade?


To: Elroy who wrote (3511)5/26/2007 1:07:40 PM
From: Mike McFarland  Read Replies (1) | Respond to of 20435
 
Another way to look at GOOG's crazy marketcap:

GOOG is twice as big as Amazon and Ebay combined!
And those in turn are both wildly overvalued. IMHO.

I think we all know that there are so many megabillion
mutual funds, and they need a big liquid growth stock
like Google. It really doesn't matter if the emperor
is half clothed or stark naked or maybe wearing some
nice clean sweat pants even. But GOOG is not the
Emperor of the internet that the marketcap suggests.

There is a good chance that at the end of the contest
I will find GOOG up 25% and my pathetic little microcap
biotech down 25%. It will be a spectacular fall to the
bottom of the pack. Proving only...don't try this at
home. But seems a resonable way to play the contest, if
only to state a point that I thought would be fun to share.

Now, the case for being long Curis...well, that is hard,
it is out of favor and sinking. You never know how low
they will go. The day may come when it sinks below a buck
a share--then maybe a reverse split. There will be these
waves of panic as yahoo daytraders gradually give up.
That is when to buy some. And I will be averaging down
(and again sweating it, my latest pet stock, ha!)

There is huge leverage when you put a bunch of PhD chemists
and biologists together. Of course Curis has also burned
through a huge amount of money--if I had owned it since 2000
I would be furious! But I still think it has prospects going
forward from here. Of course, now that it is so poorly
valued, it could be the victim of some private takeout. Then
watch...a few years from now they'll have a drug, and
a new IPO. Rinse, repeat. Public shareholders often get
screwed. It takes some luck to make money dabbling with
these microcap biotechs.